Liver Metastasis Colon Cancer
Showing 9976 - 10000 of >10,000
HepaSphere™ Microspheres Prospective Registry
Completed
- Metastatic Colorectal Cancer
- HepaSphere Microspheres
-
Paris, France
- +1 more
Jul 16, 2021
Peripheral Neuropathy, Chemo-induced Peripheral Neuropathy, Breast Cancer Trial in Alexandria (Lidocaine in Saline, Duloxetine
Completed
- Peripheral Neuropathy
- +2 more
- Lidocaine in Saline
- +2 more
-
Alexandria, EgyptEgypt Medical Research Institute
Jul 7, 2022
Metastatic Castration Resistant Prostate Cancer Trial in New York, Pittsburgh, Seoul (DZD2269)
Terminated
- Metastatic Castration Resistant Prostate Cancer
-
New York, New York
- +5 more
Jul 6, 2022
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial
Recruiting
- Anatomic Stage I Breast Cancer AJCC v8
- +21 more
-
Scottsdale, Arizona
- +2 more
May 31, 2022
Colorectal Adenocarcinoma Trial in Puerto Rico, United States (drug, dietary supplement, other)
Recruiting
- Colorectal Adenocarcinoma
- Bevacizumab
- +8 more
-
Birmingham, Alabama
- +1030 more
Sep 25, 2022
Breast Cancer, Breast Cancer Female, Breast Cancer Stage II Trial in Boston (Accelerated Proton Beam Radiation Therapy (PBT),
Not yet recruiting
- Breast Cancer
- +4 more
- Accelerated Proton Beam Radiation Therapy (PBT)
- Accelerated Photon Radiation Therapy (XRT)
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jun 12, 2023
Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in
Recruiting
- Recurrent B-Cell Non-Hodgkin Lymphoma
- +7 more
- Autologous Anti-CD19 CAR-expressing T-lymphocytes IC19/1563
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jul 14, 2022
Metastatic HER2-Negative Breast Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in Nashville (Biospecimen
Not yet recruiting
- Metastatic HER2-Negative Breast Carcinoma
- Metastatic Triple-Negative Breast Carcinoma
- Biospecimen Collection
- +3 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Mar 3, 2023
Non Small Cell Lung Cancer, KRAS Activating Mutation Trial in United States (VS-6766 and sotorasib)
Recruiting
- Non Small Cell Lung Cancer
- KRAS Activating Mutation
- avutometinib (VS-6766) and sotorasib
-
Washington, District of Columbia
- +6 more
Jan 31, 2023
Breast Cancer, Risk Reduction Trial in Oxford (Prepectoral implant-based immediate breast reconstruction)
Enrolling by invitation
- Breast Cancer
- Risk Reduction
- Prepectoral implant-based immediate breast reconstruction
-
Oxford, Oxfordshire, United KingdomSurigcal Intervention Trials Unit (SITU), Nuffield Department of
Oct 30, 2023
COlorectal BReath Analysis (COBRA2)
Recruiting
- Colorectal Cancer
- Breath test
-
London, United Kingdom
- +4 more
Apr 25, 2023
High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8
Not yet recruiting
- High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- PD-L1/IDO Peptide Vaccine
- Pembrolizumab
-
Sacramento, CaliforniaUniversity of California Davis Comprehensive Cancer Center
Apr 24, 2023
Patients With Neuroendocrine Cancer of the Cervix
Recruiting
- Cervical Large Cell Neuroendocrine Carcinoma
- +21 more
- Follow-Up
- Medical Chart Review
-
Houston, TexasM D Anderson Cancer Center
Dec 5, 2022
Diabete Type 2, Obesity Trial in Orlando (HU6)
Not yet recruiting
- Diabete Type 2
- Obesity
-
Orlando, FloridaAdventHealth Translational Research Institute
Oct 23, 2023
Testing Circulating Tumour DNA for Homologous Recombination Gene
Recruiting
- Circulating Tumor DNA
- Metastatic Prostate Cancer
- Blood sample
- Urine sample
-
Tours, FranceUniversity hospital
Sep 6, 2022
The Pandemic's Effect on Diagnosis and Treatment of Rectal
Recruiting
- Rectal Cancer
- Diagnosed during or not during the pandemic
-
Gothenburg, SwedenDept. of Surgery, Sahlgrenska University Hospital/Ostra
Apr 13, 2022
2177GCCC:ID'Ing tx Targets and Biomarkers for Ocular Surface
Recruiting
- Dry Eye Disease
- oGVHD
- The standard care exam and biological specimens' collection
-
Baltimore, MarylandGeenebaum Cancer Center, University of Maryland Medical Center
Jun 2, 2022
Esophageal Cancer Trial in Luoyang (Camrelizumab)
Recruiting
- Esophageal Cancer
-
Luoyang, Henan, ChinaThe First Affiliated Hospital of Henan University of Science and
Jan 20, 2022
Cancer Trial in Seattle (Financial navigation, Enhanced usual care)
Recruiting
- Cancer
- Financial navigation
- Enhanced usual care
-
Seattle, WashingtonKaiser Permanente Washington Health Research Institute
Aug 15, 2022
HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)
Active, not recruiting
- HER2-positive Breast Cancer
- TQB2440 injection + Trastuzumab + Docetaxel
- Perjeta + Trastuzumab + Docetaxel
-
Chongqing, Chongqing, China
- +5 more
Aug 3, 2023
Melanoma (Skin) Trial in Stockholm (LifeChamps Platform)
Active, not recruiting
- Melanoma (Skin)
- LifeChamps Platform
-
Stockholm, SwedenAcademic Primary Health Care Centre
Aug 6, 2023